UNDERWEIGHT — Trim 15-20% of existing ORCL position over 8-12 sessions with December $130/$110 put spread hedge; price target $125; mandatory reassessment at December FY27 Q2 earnings
UNDERWEIGHT rating on ORCL reflects binding technical regime (MACD negative and widening, price 50%+ below 200-SMA with SMA declining, death cross intact, all major MAs stacked bearishly) combined with capital structure deterioration ($155.9B total debt, 251% debt/equity, gross margin compression 72.8%→60.0%) and $11 forward EPS estimate implying 72% growth. However, 12.6x forward P/E with PEG 0.78 indicates much of bear case is already priced; $664B RPO floor remains contractually intact anchored by IG counterparties. Trim magnitude compressed to 15-20% (not 30-50% as proposed) to honor 9/30 ceiling constraint while avoiding alpha-leakage from pure Hold. Defined-risk put spread used instead of equity stops (prior $146 stop rejected as mechanically broken at only 1.07x ATR ~$7.00 in a beta-1.73 name with ~20% weekly survival probability). Upgrade to Hold if close >$143 on volume with RSI >50; Upgrade to Overweight requires 200-SMA reclaim + two consecutive quarters FCF narrowing + clean capex commentary; Downgrade to Sell on close <$124 on volume or material counterparty renegotiation.
| Position | Action |
|---|---|
| Close <$132.60 on volume >40M shares | Accelerate trim (confirms 9/24-style breakdown) |
| Price reclaims $143 (50 SMA) on rising volume with RSI >50 | Pause trim |
| Close <$124 on >20M volume | Hard invalidation — re-evaluate to Sell |
| Execute via VWAP or limit orders at $137-142 over 8-12 trading sessions | No market-impact signaling; no panic trim |
Oracle's 29.6% revenue acceleration, 41% ROE, and contractually-backed AI infrastructure bet make the current sub-13x forward P/E a generational mispricing opportunity as the capex moat monetizes faster than the market expects.
| Indicator | Value | Signal |
|---|---|---|
| RSI | 43.57 | neutral |
| MACD Line | -2.76 | bearish |
| MACD Signal | -1.37 | bearish |
| MACD Histogram | -1.39 | bearish |
| Bollinger Middle (20 SMA) | 146.57 | bearish |
| Bollinger Upper Band | 163.71 | bearish |
| Bollinger Lower Band | 129.43 | neutral |
| ATR | 6.88 | neutral |
| VWMA | 141.97 | bearish |
| 10 EMA | 140.35 | bearish |
| 50 SMA |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 10-year Treasury peaks and rolls over below recent highs, OR Fed pricing shifts dovish
Then: Re-evaluate for potential re-entry or upgrade
EV: +30%+ · concedes: Negative FCF of -$23.7B in FY26 is real and optics are challenging; 10-year Treasury at 2002 highs and Fed hawkish stance creates near-term headwinds; High beta (1.73) means amplified downside if macro deteriorates further; Capex cycle timing is uncertain — waiting for FCF inflection could mean missing the re-rating
Oracle is a value trap: revenue growth is being bought at the cost of margin destruction, the company cannot self-fund its AI ambitions, and the financing structure (equity dilution, massive debt) signals cash generation insufficient for stated goals, all while macro headwinds (10-year at 2002 highs, hawkish Fed) and bearish technicals (death cross, RSI 43.57, institutional distribution) suggest further downside.
EV: -$115–$120 (-15% to -20%) · concedes: Revenue is growing at 29.6% and ROE is 41%; Sentiment at 4.5/10 indicates some bearishness is already priced in; Short-term mechanical bounce possible from lower Bollinger Band touch
→ vs conservative: The conservative 'hold/wait for confirmation' thesis is flawed because the death cross is already in place, MACD is negative, and RSI at 43 means sellers haven't exhausted themselves yet—waiting for 'autopsy results' after the patient is already down 59% is stubbornness, not patience
→ vs conservative: The conservative view ignores dilution math: diluted shares up to ~3 billion from 2.77 billion three years ago, watering down any EPS growth
→ vs neutral: The neutral 'wait for FCF inflection' argument ignores that capex keeps accelerating and the FCF inflection may never come in a timeframe that matters
→ vs neutral: The neutral analyst's read-across from Accenture's 23% jump on record bookings doesn't transfer—Accenture generates positive FCF; Oracle has $156 billion in debt
→ vs neutral: The neutral analyst frames the capital raise as 'funding the future' when it's actually a company that has to keep issuing paper to keep the lights on while generating deeply negative free cash flow
| 143.15 |
| bearish |
| 200 SMA | 162.41 | bearish |
| Close Price | 138.07 | neutral |
Support: 129.43 · 132.6 | Resistance: 140.35 · 143.15 · 146.57 · 162.41 · 163.71
ORCL exhibits a confirmed bearish trend across all major timeframes with price below the 10 EMA (140.35), 50 SMA (143.15), and 200 SMA (162.41), confirming a death cross regime. The MACD remains bearish with the line below the signal and histogram negative, though the histogram is stabilizing from earlier deep negatives. RSI at 43.57 has not reached oversold territory, indicating potential downside room remains before a tradable bottom. Price is testing the lower Bollinger Band area with recent lows at $132.60, and a close below this level would target $129.43. Bullish reversal triggers to monitor include a break above the 10 EMA (140.35), reclaim of the 50 SMA (143.15), or MACD histogram flipping positive.
Market Capitalization
$418.56B
Trailing P/E
21.6x
Forward P/E
12.6x
PEG Ratio
0.77
Price/Book
6.75x
Beta
1.73
Dividend Yield
1.46%
TTM EPS
$6.38
Forward EPS Estimate
$10.99
52-Week High
$322.54
52-Week Low
$114.50
Revenue FY2023
$49.95B
Revenue FY2024
$52.96B
Revenue FY2025
$57.40B
Revenue FY2026
$67.36B
Revenue Aug 2025
$14.93B
Revenue Nov 2025
$16.06B
Revenue Feb 2026
$17.19B
Revenue May 2026
$19.18B
Revenue Aug 2026
$19.35B
Gross Margin FY2026
65.8%
Operating Margin FY2026
33.3%
Net Margin FY2026
25.4%
Diluted EPS FY2023
$3.07
Diluted EPS FY2026
$5.83
R&D Expense
$10.27B
Cost of Revenue
$23.02B
Cash and ST Investments
$37.08B
Total Assets
$303.26B
Total Debt
$155.93B
Long-Term Debt
$117.71B
Capital Lease Obligations
$30.59B
Stockholders' Equity
$66.77B
Net Debt
$88.97B
Debt/Equity
251.7%
Current Ratio
1.17x
PPE Growth
$53.2B to $161.8B
Operating Cash Flow FY2026
$31.98B
Capital Expenditures FY2026
$55.66B
Free Cash Flow FY2026
-$23.69B
Dividends Paid FY2026
$5.79B
Return on Equity
41.2%
Return on Assets
6.4%
Asset Turnover
~0.24x
Diluted Shares Outstanding
3.00B
Equity Issuance Aug 2026
$19.9B
Goodwill
$62.3B
Interest Expense
$1.4B/qtr
Net Interest Expense
>$1.1B/qtr
New Debt Issued FY2026
$49.4B
Strengths
Concerns
Oracle is mid-cycle transformation story: a profitable, high-margin legacy software business (net margin 25.4%, ROE 41%) funding an aggressive $55.7B/year AI/cloud infrastructure build-out via debt and equity. Revenue is inflecting sharply (+29.6% YoY latest quarter), but FCF is deeply negative (-$23.7B) as capex explodes 6x in three years. The stock trades -57% from its 52-week high at a forward P/E of 12.6x, reflecting market concerns about capital discipline and cloud monetization risk. HOLD is appropriate — wait for FCF inflection or further drawdown.
Macro: The macro backdrop is mixed-to-hostile for high-multiple software infrastructure: 10Y Treasury yield at highest level since 2002 with biggest monthly gain since 2022; Polymarket shows 1% probability of Fed cut by Oct 2026, 3% by Dec 2026 (down 0.4pp WoW), 6% by Jan 2027 (down 3.0pp WoW), 22% by Mar 2027, and 60% by Jul 2027 (up 11pp WoW). US recession probability by end-2026 is 8% (down 2pp WoW). Multiple Fed officials signaling hawkish stance with 'more work to do' on inflation. Accenture reported +23% on record bookings confirming enterprise IT demand re-acceleration. IBM +5% on hybrid/enterprise AI validates Oracle's similar positioning. Software-Defined Networking market projected at $82.59B by 2030 (18.2% CAGR).